Skip to main content
editorial
. 2017 Aug 6;8(3):155–161. doi: 10.4292/wjgpt.v8.i3.155

Table 1.

Management of secondary loss of response

No/low antibody level High antibody level
Low drug level Increase drug dose Change therapy (within class or alternate class)
Normal/high drug level Change therapy (alternate class) (Not clinically relevant scenario)